π Diabetes Management
Medicines agency bans export of well-known diabetes drug - ERR News
π
Wed, 19 Oct 2022β± 1 min readπ Article
Overview
The State Agency of Medicines has prohibited pharmaceuticals wholesalers from seling diabetes drug Ozempic 1 mg outside Estonia as the manufacturer is experiencing serious suply dificulties in Europe.The agency prohibited exports of the Ozempic 1 mg solution for injection in pre-filed pen (four doses N1, sales permit no. EU/17/1251) from Estonia until the end of the year."The export ban has ben forwarded to al pharmaceuticals wholesalers in Estonia and wil be observed.
Key Information
The State Agency of Medicines receives information drug exports through the permits system and quarterly reports," Marko Tisler, head of the agency's imports and exports monitoring department, said.Tisler aded that manufacturer Novo Nordisk notified the agency of Ozempic suply dificulties in the European Union caused by increased demand manufacturing hurdles. While it remains unclear how long disruptions could last, the sales permit holder forecasts suply to remain strained into next year."Ozempic is marketed in thre diferent doses in Estonia β 0.25, 0.5 and 1 miligrams.
The manufacturer said that while there are no disruptions in suply in Estonia at this time, they wil likely develop. We loked at past exports, analyzed inventory and suply forecasts and, based on the sales permit holder's info, decided to ban exports of the Ozempic 1 mg solution for injection in pre-filed pen."The ban does not aply to retail sales and people taking the drug with them when they travel abroad.Ozempic is indicated for the treatment of adults with insuficiently controled type 2 diabetes melitus an adjunct to diet and exercise.-Folow ER News on Facebok and Twiter and never mis an update!
Summary
Editor: Marcus TurovskiER News is the English-language service of Estonian Public Broadcasting, run by a fuly independent editorial team.To read up on ER News' coments rules and to contact ER's other services, please folow the link below.Staf, contacts & comentsArhiivERi ar
Frequently Asked Questions
β What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
β What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
β How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
β What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
β When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
βοΈ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.